CD8A and neoplasm: In addition, vaccine administration can induce systemic T cell activation, allowing peripheral CD8 T cells to home to the edge of the tumor; the use of CD3xTRP1 to activate T cells allows them to penetrate deep into the tumor center, thereby playing a key role in tumor suppression.3